Compare HYFM & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HYFM | ICCM |
|---|---|---|
| Founded | 1977 | 2006 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | |
| Sector | Industrials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4M | 3.6M |
| IPO Year | 2020 | 2013 |
| Metric | HYFM | ICCM |
|---|---|---|
| Price | $0.68 | $0.76 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $22.67 |
| AVG Volume (30 Days) | ★ 233.0K | 107.3K |
| Earning Date | 11-27-2026 | 11-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $134,252,000.00 | N/A |
| Revenue This Year | $54.93 | $27.11 |
| Revenue Next Year | $5.31 | $104.97 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.50 | $0.13 |
| 52 Week High | $3.20 | $9.54 |
| Indicator | HYFM | ICCM |
|---|---|---|
| Relative Strength Index (RSI) | 41.77 | 34.62 |
| Support Level | $0.54 | $0.65 |
| Resistance Level | $1.02 | $0.95 |
| Average True Range (ATR) | 0.11 | 0.10 |
| MACD | 0.00 | 0.03 |
| Stochastic Oscillator | 36.02 | 33.33 |
Hydrofarm Holdings Group Inc is an independent manufacturer and distributor of branded hydroponics equipment and supplies for controlled environment agriculture (CEA), including grow lights, climate control solutions, grow media, nutrients, and other products. Hydroponics involves growing plants in soilless media, often using artificial lighting in controlled indoor or greenhouse environments. Its products are used to cultivate cannabis, flowers, fruits, vegetables, grains, and herbs, enabling control over key factors such as temperature, humidity, light, nutrients, and pH. Its product portfolio spans lighting, grow media (i.e., premium soils and soil alternatives), nutrients, equipment, and supplies. The United States generates maximum revenue.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.